Table 4.

Unmet needs in treating PsA patients: addressing the problem^*

Unmet needs in treating PsA patients

Available treatment algorithms have not been validated

No clear consensus exists on treatment success

Physicians and patients are unclear and sometimes do not agree on the components that constitute treatment success and/or how it should be measured

No available validated composite index combines and balances physician- and patient-oriented outcomes

Addressing the problem

Educate rheumatologists

Identify patients at high risk for disease progression

Provide timely and appropriate intervention

Communicate and/or educate dermatologists on appropriate referrals to rheumatologists

Validate current treatment algorithms (such as EULAR)

Develop and validate definitions for treatment response and remission

Develop and validate a composite assessment instrument that considers all manifestations of PsA

Improve communication between health care providers and patients to ensure that expectations are matched

^*PsA = psoriatic arthritis; EULAR = European League Against Rheumatism.